Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, topical nitroglycerine spray successfully prevented impending necrosis in 94% of hair transplant cases showing signs of vascular distress.

This paper introduces a novel topical booster aimed at enhancing follicular sulfotransferase activity to potentially improve minoxidil response in patients with androgenetic alopecia but reports no new clinical results.

This study found that topical corticosteroid foams are effective and generally preferred by patients for a variety of corticosteroid-responsive skin conditions, demonstrating significant clinical benefits such as improved psoriasis symptoms and hair regrowth in alopecia areata compared to traditional forms.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

In this study, topical calcipotriol was found to be more effective than oral vitamin D for improving mild to moderate alopecia areata, with a 68% improvement rate and no correlation between serum vitamin D levels and treatment efficacy.

This study suggests that the InlB321/15 protein may accelerate wound healing by increasing cell proliferation and reducing wound closure time in both cell culture and mouse models.

In this study, Spectral DNC-N® significantly reduced hair shedding and increased hair mass and density in women with early female pattern hair loss, with effects evident after 3 months and sustained through 6 months.

This study reports a case of pustular allergic contact dermatitis following the use of 5% minoxidil solution in a female patient, highlighting an uncommon reaction to a frequently used dermatological treatment.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Using minoxidil and tretinoin on the skin, along with oral vitamin D, improved hair thickness and density in two girls with woolly hair.

This report describes two cases of Rapp–Hodgkin ectodermal dysplasia where refractory scalp erosions improved significantly with potent topical steroids; it also suggests a potential link between these scalp conditions and erosive pustular dermatosis of the scalp in elderly patients.

This study suggests that 2% minoxidil and Kerium may promote hair regrowth in rats, while Aminexil showed the least effect among tested treatments; human-use products varied in efficacy in this animal model.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

This study reports that topical iodine can initiate, control, and complete the regeneration of human scar tissue, with hair playing a key role in the process.

This study found that six months of using finasteride cream 0.5% did not significantly change the number or thickness of facial hair in women with hirsutism, although patients felt hair growth slowed.

In this study, daily topical minoxidil treatment in neonatal hairless pups led to increased hair growth and the development of hair follicles in the treated areas.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

This study found that 3% topical minoxidil decreased hair shedding and promoted hair growth in women with androgenetic alopecia.

This study observed that topically applied 2% minoxidil solution significantly increased hair counts in men with early male pattern alopecia over 24 weeks, with no serious safety concerns.

This survey found that over 70% of dermatologists in the sample had prescribed topical minoxidil for hair loss, with low reported complications beyond local irritation.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

In this study, combining compound glycyrrhizin with topical minoxidil was more effective and as safe as minoxidil alone for treating alopecia areata.

This study found that topical DPCP was more effective for hair regrowth in resistant alopecia areata compared to anthralin, with both treatments having similar safety profiles.

This study examines the use of emulgel-based systems as drug delivery vehicles for hydrophobic medications, noting their potential benefits in dermatological applications due to properties like easy spreadability, non-greasy texture, and prolonged shelf life.

This study reported that topical spironolactone improved lid margin vascularity, corneal fluorescein staining, and disease severity scores in patients with ocular graft-versus-host disease, suggesting a potential therapeutic role by enhancing corneal lipid production with minimal adverse effects.

This study evaluated a new topical regenerative treatment and found it can safely and effectively reduce hair loss in patients with androgenetic alopecia and telogen effluvium by mimicking the effects of autologous platelet-rich plasma.

This review found that both oral and topical soy-based products showed positive effects on various skin-related outcomes, including aging signs and skin barrier function, but topical applications were more likely to improve skin barrier status compared to oral supplementation.

In a mouse model, this study found that nano-sized molybdenum accelerated hair growth and reduced oxidative stress markers, with enhancements observed when combined with minoxidil. It suggests potential for this combination as a novel topical treatment for hair loss, pending further clinical validation.

In laboratory experiments, this study found that the topical prodrug SCD-153, a derivative of 4-methyl itaconate, reduced inflammation-related gene expression and induced significant hair growth in mice, suggesting it as a promising treatment candidate for alopecia areata.